Naoxintong Protects against Atherosclerosis through Lipid-lowering and Inhibiting Maturation of Dendritic Cells in LDL Receptor Knockout Mice fed a High-fat Diet
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
5891-5896
Author(s):
Xueting Jin, Junbo Ge, Aijun Sun, Kai Hu, Yunzeng Zou, Keqiang Wang, Lifu Jia, Tao Zhao, Buchang Zhao, Jingjing Zhao, Shuxia Fan, Hangtian Zhao, Cong Wang, Xiangwei Liu, Xin Ma, Shijun Wang and Hong Zhu
Dendritic Cells in Atherosclerosis
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
5883-5890
Author(s):
Siân P. Cartland and Wendy Jessup
Augmentation Therapy with Alpha1-antitrypsin: Novel Perspectives
Journal:
Cardiovascular & Hematological Disorders-Drug Targets
Volume:
13
Page:
90-98
Author(s):
Janciauskiene Sabina and Welte Tobias
Catastrophic Antiphospholipid Syndrome - 20 Years Later
Journal:
Current Rheumatology Reviews
Volume:
9
Page:
73-80
Author(s):
Ignasi Rodríguez-Pintó, Gerard Espinosa and Ricard Cervera
Systemic and Biophase Bioavailability and Pharmacokinetics of Nanoparticulate Drug Delivery Systems
Journal:
Current Drug Delivery
Volume:
10
Page:
208-240
Author(s):
Sorin Emilian Leucuta
Advances in Drug Safety
Journal:
Current Pharmaceutical Design
Volume:
18
Page:
6266-6283
Author(s):
J. Adam Cartwright, Steven Aniskevich III, Christopher B. Robards, Harish Ramakrishna, Sorin J. Brull and Steven R. Clendenen
Recent Advances in Perioperative Anesthetic Management Update in the Perioperative Support of Patients with Septic Shock and the Effect on Outcomes
Journal:
Current Pharmaceutical Design
Volume:
18
Page:
6298-6307
Author(s):
Aaron Douglas, Ellen Wurm, Patrick Pickett and J. Steven Hata
P2X7 Receptors: Channels, Pores and More
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
11
Page:
705-721
Author(s):
C. Volonte, S. Apolloni, S. D. Skaper and G. Burnstock
Non-Analgesic Effects of Opioids: Neuroprotection in the Retina
Journal:
Current Pharmaceutical Design
Volume:
18
Page:
6101-6108
Author(s):
Shahid Husain, Yasir Abdul and David E. Potter
Biology and Clinical Management of Myeloproliferative Neoplasms and Development of the JAK Inhibitor Ruxolitinib
Journal:
Current Medicinal Chemistry
Volume:
19
Page:
4399-4413
Author(s):
J. Mascarenhas, T. I. Mughal and S. Verstovsek